Book·2025·332 pages
Course·45 min·6 chapters
Leucovorin for Autism Spectrum Disorder Treatment
After 45 minutes you will know the research behind in autism, and how is tested for, treated and monitored.
- Length
- 45 min
- Chapters
- 6
- Format
- On-demand video
- Taught by
- Richard E. Frye, MD, PhD
- Credit
- No CME credit
- Price
- $95
You create an account and pay on Metabolic Learning Resource, and this site takes no payment. The course is sold by Metabolic Learning Resource, founded by Dr. Frye.
Before you enroll
Who is this course for?
Families
Parents and caregivers who want to understand testing, treatment and monitoring before they talk with their child’s doctor.
Clinicians
Clinicians who want the research history and an outline of testing, treatment and monitoring. No CME credit is offered.
Leucovorin is not an “autism pill”
It is a prescription medicine that needs the right patient, dose and formulation. This course is education, not a treatment plan.
What it covers
One treatment, followed from its research history to monitoring a child’s response. A handout and a rating scale are included.
The research history
How leucovorin came to be studied in autism.
Testing
How to test for cerebral folate deficiency.
Treatment
How treatment with leucovorin is approached.
Monitoring
How to monitor response to treatment.
Format
On-demand video in 6 chapters, 45 minutes in all.

Your instructor
Richard E. Frye, MD, PhD
Dr. Frye is a pediatric neurologist, and the foundation’s Chief Scientific Officer and cofounder. He has studied leucovorin in autism for about two decades, and led the first double-blind, placebo-controlled trial of it in 2018. His research has been supported in the past by the National Institutes of Health, the Department of Defense and Autism Speaks.
Related
The book, the topic and the first trial.
Topic·11 papers
Could my child’s brain be low in folate?
Paper·2018·Clinical trial
Folinic acid improves verbal communication in children with autism and language impairment: a randomized double-blind placebo-controlled trial
The first double-blind, placebo-controlled trial of leucovorin in autism. Over 12 weeks, 23 children on leucovorin improved in verbal communication compared with 25 on placebo.
Questions
Is this medical advice?
No. The course explains the research and how clinicians approach testing and treatment, so that you can have a better conversation with a clinician. It does not replace one.
Does it give CME credit or a certificate?
No CME credit is offered.
How long do I keep access, and can I get a refund?
Access and refunds are set by Metabolic Learning Resource, where you enroll.
Where does the money go?
The course is sold by Metabolic Learning Resource, founded by Dr. Frye. You pay there, and this site takes no payment. To support the foundation’s research directly, give to the foundation.
This course is not medical advice
It is for education and is not a substitute for a consultation with a qualified clinician. Leucovorin is a prescription medicine; decisions about it belong with your child’s doctor.